Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000245695 | SCV000317527 | benign | Cardiovascular phenotype | 2015-06-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000598010 | SCV000701114 | benign | not specified | 2016-12-16 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713776 | SCV000844406 | benign | not provided | 2018-05-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001520751 | SCV001729932 | benign | DiGeorge syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713776 | SCV001894596 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000598010 | SCV003928649 | likely benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000598010 | SCV001918598 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000598010 | SCV001930447 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000598010 | SCV001953061 | benign | not specified | no assertion criteria provided | clinical testing |